GLP-1 receptor agonists and adverse outcomes in patients with type 2 diabetes and chronic viral hepatitis
Clinical and molecular hepatology · 2026 Oct 27 · Zhang X, Mao X, Barnet S et
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 26 20:00 ETSource: Clinical and molecular hepatology
From the source
Read at pubmed.ncbi.nlm.nih.govGLP-1 receptor agonists and adverse outcomes in patients with type 2 diabetes and chronic viral hepatitis
Clinical and molecular hepatology · 2026 Oct 27 · Zhang X, Mao X, Barnet S et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42935235/
